| Authors: |
Kim K; R&D center, CellabMED Inc., Seoul, Republic of Korea., Song SW; CellabMED Inc., Seoul, Republic of Korea., Jeon Y; R&D center, CellabMED Inc., Seoul, Republic of Korea., Choi S; R&D center, CellabMED Inc., Seoul, Republic of Korea., Choi J; R&D center, CellabMED Inc., Seoul, Republic of Korea., Jun S; R&D center, CellabMED Inc., Seoul, Republic of Korea., Park JH; CGT center, CellabMED Inc., Seoul, Republic of Korea., Lee SJ; CGT center, CellabMED Inc., Seoul, Republic of Korea., Han N; Department of Pathology and Translational Genomics, Samsung Medical Center, Seoul, Republic of Korea., Dho YS; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Shin SH; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Yoo H; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Wang KC; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Gwak HS; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea. |